Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mercian discovers other anthracycline antineoplastic agents

Dec. 20, 1996

Heterologous vectors for boosting antitumor immunity available for licensing

Dec. 19, 1996

Licensees sought for vector for polynucleotide vaccines

Dec. 19, 1996

Circularly permuted proteins and fusion proteins available for licensing

Dec. 19, 1996

Clinical trial on OXiGENE's Sensamide/Neu-Sensamide nearing completion

Dec. 19, 1996

Positive phase II results with RMP-7/carboplatin

Dec. 19, 1996

Prostate cancer gene therapy trial commences

Dec. 19, 1996

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Chemopreventive effects of Targretin in breast cancer

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...